
|Articles|December 14, 2017
TFS Partners With OmniComm to Use TrialMaster® EDC
Advertisement
TFS International has signed a new three-year partnership agreement with OmniComm Systems, Inc. in which TFS will use OmniComm’s TrialMaster EDC technology to develop clinical studies in multiple TFS research sites around the world. Clinical trial managment along with new medicines being brought to the market are a few of the benefits to this collaboration.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Recruitment in the Age of AI: Q&A with John Worden, Javara
2
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
3
Why Seizure Counts Alone Can't Define Success in Epilepsy Trials
4
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
5




